HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
ETFs    Mutual Fund #1 Ranked    Top Funds    Screener    Compare Funds    FAQ    Help    
Quote:
Login Free Membership
Search:

Best of Funds  

Top 5 Healthcare Mutual Funds

Share
By: Zacks Investment Research
December 15, 2010 | Comment(s): 0
Recommended this article (6)

The healthcare sector has become an especially viable option for parking investments when markets are headed south. Since the demand for such services usually remains unchanged by the state of the economy, they provide good protection for capital invested. Many several pharmaceutical companies also provide regular dividends, which can cushion losses from falling share prices. Healthcare mutual provide the perfect avenue for investors looking to invest in this sector.

Below we will share with you 5 top rated health mutual funds. Each has earned a Zacks #1 Rank (Strong Buy) as we expect these mutual funds to outperform their peers in the future. To view the Zacks Rank and past performance of all health funds, then click here.

Wells Fargo Advantage Health Care A (EHABX) seeks capital growth over the long term. The fund primarily invests in healthcare companies of all sizes. This includes companies engaged in the development or production of products or services for the sector or those that derive a significant portion of their revenue from this segment. The health mutual fund has a ten year annualized return of 3.83%.

The health mutual fund has a minimum initial investment of $1,000 and an expense ratio of 1.81% compared to a category average of 1.77%.

Rydex Biotechnology (RYOIX) invests substantially in equity securities and derivatives issued by domestic biotechnology companies. It is non-diversified and seeks long-term capital growth. The health fund returned 19.75% in the last one year and has a three year annualized return of 2.06%.

Michael P. Byrum is the fund manager and has managed this health fund since 1998.

Putnam Global Health Care A (PHSTX) seeks long-term capital growth. The fund invests primarily in companies from the health care sector across the globe. It focuses on acquiring common stocks of large and mid-cap companies. The health mutual fund returned 9.61% over the last one year period.

As of September 2010, this health mutual fund held 65 issues, with 7.53% of its total assets invested in Pfizer Inc.

Invesco Global Health Care A (GGHCX) invests primarily in companies from the health care sector. It purchases securities from issuers located in at least three countries, including the US. Up to 50% of its assets may be invested in any one country, apart from the US. The health mutual fund has a ten year annualized return of 3.72%.

The health mutual fund has a minimum initial investment of $1,000 and an expense ratio of 1.31% compared to a category average of 1.77%.

Manning & Napier Life Sciences (EXLSX) seeks capital appreciation. The fund invests heavily in securities of companies from the life sciences sector. Domestic and foreign equity, ADRs and U.S. dollar denominated foreign securities make up the majority of its assets. The health mutual fund returned 16.93% over the last one year and has a five year annualized return of 4.93%.

Jeffrey A. Herrmann is the fund manager and has managed this health fund since 1999.

To view the Zacks Rank and past performance of all health mutual funds, then click here.

About Zacks Mutual Fund Rank

By applying the Zacks Rank to mutual funds, investors can find funds that not only outpaced the market in the past but are also expected to outperform going forward. Learn more about the Zacks Mutual Fund Rank at http://www.zacks.com/funds.

Read the full analyst report on EHABX

Read the full analyst report on RYOIX

Read the full analyst report on PHSTX

Read the full analyst report on GGHCX

Read the full analyst report on EXLSX

Top Mutual Funds from Zacks
 

Please login to Zacks.com or register to post a comment.



Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
7 Best Stocks for the Next 30 Days
Get your free Welcome Gifts today*:
 1.  Special Report with best short-term Zacks recommendations from the list that averages a gain of +26% per year
 2.  Our free e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 26, 2012 09:10 am ET
DJIA 12454.83  -74.92 -0.60%
NASD 2837.53  -1.85 -0.07%
S&P 500 1317.82  -2.86 -0.22%
Partner Center